Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today. More
Articles
LTM Stock IPO: 7 Things to Know as LATAM Airlines Returns to the NYSE
LATAM Airlines stock is back on the NYSE alongside an IPO for LTM shares after they were delisted from the market back in 2020. More
3 Blue-Chip Stocks to Buy for the Second Half of 2024
Despite recent scrutiny, blue-chip stocks offer a chance to capitalize on market lulls and a sector snapback More
3 Infrastructure Stocks to Buy in Preparation for Rate Cuts
Dive into infrastructure stocks poised for gains with upcoming interest rate cuts and healthy U.S. funding. More
Serve Robotics (SERV) Stock Keeps Trending After Nvidia-Fueled Rally
SERV stock is very volatile this morning but currently up 5% after jumping 40% yesterday. The shares have soared 500% in just over a week. More
3 High-Flying Tech Stocks Facing Valuation Concerns
Traders are rotating out of overvalued tech stocks as they believe that lower interest rates may make some other sectors more attractive. More
3 Semiconductor Stocks to Bet On for Market-Crushing Returns
Buy top semiconductor stocks set to deliver market-crushing returns in AI, networking and automotive technologies. More
